Veery Capital LLC acquired a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 6,000 shares of the company's stock, valued at approximately $324,000. Veery Capital LLC owned 0.06% of Semler Scientific as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Cerity Partners LLC lifted its position in shares of Semler Scientific by 91.5% in the 3rd quarter. Cerity Partners LLC now owns 1,345,586 shares of the company's stock worth $31,689,000 after purchasing an additional 642,982 shares during the period. Shariaportfolio Inc. purchased a new stake in Semler Scientific during the third quarter worth $3,618,000. AQR Capital Management LLC boosted its position in Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company's stock valued at $4,833,000 after acquiring an additional 84,314 shares in the last quarter. Crawford Fund Management LLC bought a new stake in Semler Scientific during the 3rd quarter valued at $883,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Semler Scientific by 18.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company's stock valued at $4,341,000 after acquiring an additional 19,552 shares during the period. 49.37% of the stock is owned by institutional investors.
Semler Scientific Stock Up 11.1 %
Shares of NASDAQ SMLR traded up $6.44 during mid-day trading on Friday, reaching $64.68. 476,828 shares of the company were exchanged, compared to its average volume of 583,248. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $81.56. The firm has a 50-day moving average of $59.12 and a 200 day moving average of $39.37. The stock has a market cap of $599.58 million, a price-to-earnings ratio of 31.55 and a beta of 1.18.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million during the quarter.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
